Module 1: Introduction to Regulatory Affairs in Clinical Research

• Overview of the role and responsibilities of regulatory affairs professionals. 

• Understanding the drug development process and the importance of regulatory compliance. 

• Key stakeholders in clinical research: sponsors, CROs, IRBs, and regulatory agencies. 

Module 2: U.S. Food and Drug Administration (FDA) Regulatory Framework

• Structure and function of the FDA. 

• Key regulations governing clinical trials: 21 CFR Parts 50, 56, 312, and 314. 

• Introduction to the Code of Federal Regulations (CFR) and its application in clinical research. 

Module 3: Good Clinical Practice (GCP) and Ethical Considerations

• Principles of GCP and their implementation in clinical trials. 

• Historical evolution of clinical research ethics, including the Declaration of Helsinki. 

• Informed consent process and protection of human subjects. 

Module 4: Clinical Trial Design and Methodology

• Types of clinical trial designs: Phase I-IV studies. 

• Randomization, blinding, and control groups. 

• Statistical considerations and sample size determination. 

Module 5: Investigational New Drug (IND) Application Process

• Purpose and components of an IND application. 

• Preclinical requirements and submission procedures. 

• FDA review process and communication with sponsors. 

Module 6: Institutional Review Boards (IRBs) and Ethics Committees

• Role and responsibilities of IRBs in clinical research. 

• Submission requirements and review processes. 

• Addressing ethical dilemmas and ensuring participant safety. 

Module 7: Clinical Trial Operations and Compliance 

• Site selection, initiation, and management. 

• Monitoring procedures and ensuring protocol adherence. 

• Handling protocol deviations and implementing corrective actions. 

Module 8: Adverse Event Reporting and Safety Monitoring 

• Identification and classification of adverse events. 

• Reporting requirements to regulatory agencies and IRBs. 

• Risk assessment and management strategies. 

Module 9: New Drug Application (NDA) and Biologics License Application (BLA) 

• Structure and content of NDA and BLA submissions. 

• Compilation of clinical data and efficacy summaries. 

• Post-submission FDA review and approval process. 

Module 10: Post-Marketing Surveillance and Pharmacovigilance 

• Requirements for post-marketing studies and commitments. 

• Signal detection and risk evaluation. 

• Implementing Risk Evaluation and Mitigation Strategies (REMS). 

Module 11: Regulatory Affairs for Medical Devices 

• Classification of medical devices and regulatory pathways. 

• Premarket Notification (510(k)) and Premarket Approval (PMA) processes. 

• Quality System Regulation (QSR) and compliance requirements. 

Module 12: International Conference on Harmonisation (ICH) Guidelines 

• Overview of ICH and its impact on global clinical trials. 

• ICH E6: GCP guidelines and their implementation. 

• Harmonization efforts and challenges in multinational studies. 

Module 13: Regulatory Strategy and Intelligence 

• Developing effective regulatory strategies for product development. 

• Conducting regulatory intelligence and staying updated with changes. 

• Engaging with regulatory agencies and advisory committees. 

Module 14: Quality Assurance and Auditing in Clinical Trials 

• Principles of quality assurance and quality control. 

• Conducting internal audits and preparing for regulatory inspections. 

• Addressing findings and implementing continuous improvement. 

Module 15: Medical Writing and Regulatory Documentation 

• Preparing clinical study reports and regulatory submissions. 

• Writing Investigator’s Brochures and informed consent documents. 

• Ensuring clarity, accuracy, and compliance in medical writing